Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7);Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy

Infection

Volumn 45, Issue 6, 2017, Pages 849-856

  Giacobbe, Daniele Roberto ^a   Del Bono, Valerio ^a   Mikulska, Malgorzata ^a   Gustinetti, Giulia ^a   Marchese, Anna ^a   Mina, Federica ^a   Signori, Alessio ^b   Orsi, Andrea ^a   Rudello, Fulvio ^c   Alicino, Cristiano ^a   Bonalumi, Beatrice ^a   Morando, Alessandra ^a   Icardi, Giancarlo ^a   Beltramini, Sabrina ^a   Viscoli, Claudio ^a   Ferrazin, Antonio ^d   Dodi, Ferdinando ^d   Morandi, Norberto ^d   Toscanini, Federica ^d   Camera, Marco ^d   Di Biagio, Antonio ^d   Mazzarello, Giovanni ^d   Alessandrini, Anna Ida ^d   De Maria, Andrea ^d   Delfino, Emanuele ^d   Nicolini, Laura Ambra ^d   Saffioti, Carolina ^d   Magnè, Federica ^d   Gandolfo, Nemo ^d   more..

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SANTALUCIA PHARMA APPS   (Italy)

^d NONE

Author keywords

Antibiotics; Antifungals; Antimicrobial resistance; Antimicrobial stewardship; Carbapenems; CDI; Clostridium; CPE; CRE; DDD; Klebsiella; KPC

Indexed keywords

AMINOGLYCOSIDE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; DAPTOMYCIN; ECHINOCANDIN; FLUCONAZOLE; GLYCOPEPTIDE; LINEZOLID; MACROLIDE; METRONIDAZOLE; QUINOLONE DERIVATIVE; TIGECYCLINE;

ARTICLE; BLOODSTREAM INFECTION; CANDIDA; CONFIDENCE INTERVAL; DRUG USE; EDUCATION PROGRAM; EDUCATIONAL STATUS; HUMAN; ITALY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED EDUCATIONAL AND SEMI RESTRICTIVE ANTIMICROBIAL STEWARDSHIP; PRESCRIPTION; TEACHING HOSPITAL; TREND STUDY; ANTIMICROBIAL STEWARDSHIP; BACTEREMIA; BLOOD; CANDIDIASIS; INCIDENCE; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIMICROBIAL STEWARDSHIP; BACTEREMIA; CANDIDIASIS; HOSPITALS, TEACHING; INCIDENCE; ITALY;

EID: 85028592748     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-017-1068-2     Document Type: Erratum

References (30)

1. Marston HD, Dixon DM, Knisely JM, et al. Antimicrobial resistance. JAMA. 2016;316:1193–204.
2. Fauci AS, Marston ID. The perpetual challenge of antimicrobial resistance. JAMA. 2014;311:1853–4.
3. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 2007;3:541–8.
4. Schmieder R, Edwards R. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol. 2012;7:73–89.
5. Giacobbe DR, Del Bono V, Trecarichi EM, De Rosa FG, Giannella M, Bassetti M, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect. 2015;21:1106.e1–8.
6. Alicino C, Giacobbe DR, Durando P, et al. Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population. Epidemiol Infect. 2016;144:2517–26.
7. Asensio A, Di Bella S, Lo Vecchio A, et al. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study. Int J Infect Dis. 2015;36:31–8.
8. Falcone M, Tiseo G, Tascini C, et al. Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: a multicenter study. Eur J Intern Med. 2017;. doi:10.1016/j.ejim.2017.03.005.
9. Šuljagić V, Miljković I, Starčević S, et al. Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case–control study. Antimicrob Resist Infect Control. 2017;6:31.
10. Adams DJ, Elberly MD, Rajnik M, et al. Risk factors for community-associated Clostridium difficile in children. J Pediatr. 2017;. doi:10.1016/j.jpeds.2017.03.032.
11. Del Bono V, Giacobbe DR. Bloodstream infections in internal medicine. Virulence. 2016;7:353–65.
12. De Rosa FG, Corcione S, Raviolo S, et al. Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropethogenetic opportunistic syndromes? Infez Med. 2015;23:105–16.
13. Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes–what’s missing? J Antimicrob Chemother. 2010;65:2275–7.
14. Hamilton KW, Fishman NO. Antimicrobial stewardship interventions: thinking inside and outside the box. Infect Dis Clin N Am. 2014;28:301–13.
15. White AC, Atmar RL, Wilson J, et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997;25:230–9.
16. Pear SM, Williamson TH, Bettin KM, et al. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994;120:272–7.
17. Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24:699–706.
18. Solomon DH, Van Houten L, Glynn RJ. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001;161:1897–902.
19. Ben-Ami R, Olshtain-Pops K, Krieger M, Israeli Candidemia Study Group, et al. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother. 2012;56:2518–23.
20. Ananda-Rajah MR, Slavin MA, Thursky KT. The case for antifungal stewardship. Curr Opin Infect Dis. 2012;25:107–15.
21. Denning DW, Perlin DS, Muldoon EG, et al. Delivering on antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg Infect Dis. 2017;23:177–83.
22. Centers for Disease Control and Prevention. National Health Safety Network multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) module (http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf). Accessed 20 April 2017.
23. European Centre for Disease Control and Prevention. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Protocol version 4.3, 2012. http://ecdc.europa.eu/en/publications/publications/0512-ted-pps-hai-antimicrobial-use-protocol.pdf. Accessed 20 April 2017.
24. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;15(62):e51–77.
25. Conte V, Monaco M, Giani T, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage. J Antimicrob Chemother. 2016;71:3386–91.
26. Alicino C, Giacobbe DR, Orsi A, et al. Trends in the incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy. BMC Infect Dis. 2015;15:415.
27. Giacobbe DR, Del Bono V, Marchese A, et al. Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? Clin Microbiol Infect. 2014;20:O1157–8.
28. Cristina ML, Alicino C, Sartini M, et al. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area. J Infect Public Health. 2017;. doi:10.1016/j.jiph.2017.06.003.
29. Okamoto K, Lin MY, Haverkate M, et al. Modifiable risk factors for the spread of Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae among long-term acute-care hospital patients. Infect Control Hosp Epidemiol. 2017;. doi:10.1017/ice.2017.62.
30. Tumbarello M, Trecarichi EM, Tumietto F, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2014;58:3514–20.